Recombinant human interleukin-2 (IL-2) expressed as Escherichia coli was isolated as insoluble aggregates of protein (inclusion bodies) after cell breakage. IL-2 and contaminants were dissolved in 6 M-guanidinium chloride/ 10 mM-dithiothreitol, pH 8.5, and further purified in reduced and denatured form by gel-permeation chromatography in the same solvent. Renaturation was effected by dilution and autoxidation; IL-2 of native specific activity was isolated at over 95% purity by reversed-phase h.p.l.c.; an additional peak of reduced protein was also observed. Most losses of native IL-2 occurred on refolding, probably because of an aggregation process; concentrations around 1 jug/ml were necessary to achieve 30% recovery. It was essential to maintain the denatured protein in reduced form before renaturation and autoxidation, which was most efficient at pH 8.5 with 1.5 /M-CuSO4. A procedure based on these observations has been used to prepare IL-2 on the 50 ,g scale.
INTRODUCTION
Interleukin 2 (IL-2) or T-cell growth factor, is a 15 500Mr single-subunit protein produced by Tlymphocytes that promotes the proliferation of activated T-cells (Robb, 1985) . In addition it modulates growth and differentiation of other lymphocyte subsets, for example causing maturation of cytotoxic T-cells (Ezard et al., 1985) , induction of y-interferon (Farrar et al., 1981) and promotion of natural killer-and lymphokineactivated-killer-cell activity (Hinney et al., 1981; Mule et al., 1985) .
IL-2 has been purified from natural and recombinant sources by a variety of methods, usually involving RP-h.p.l.c. (Henderson et al., 1983; Stern et at., 1984) as the principal purification step. The human IL-2 gene has been cloned and expressed in Escherichia coli as insoluble 'inclusion bodies' (Devos et al., 1983) . Inclusion bodies are dense aggregates, largely of recombinant protein and 2-3,um in diameter, that can be separated from soluble bacterial proteins by low-speed centrifugation after cell lysis (Schoner et al., 1985) . In most cases inclusion bodies need to be dissolved in denaturing solvent and the protein then refolded and purified (Marston et al., 1984) . Proteins vary considerably in their optimal conditions for renaturation; various factors such as pH, salt concentration and type, rate of removal of denaturant, concentration of the target protein and of contaminants may strongly affect the recovery of authentic protein (Ghelis & Yon, 1982) . Since IL-2 has one disulphide bridge and one free cysteine residue, redox conditions must also be considered so as to provide oxidation without excessive formation of wrong disulphides. The purification of recombinant IL-2 has been described in outline and the protein thoroughly characterized (Kato et al., 1985; Liang et al., 1985; Yamada et al., 1986) .
In the present paper we describe in detail the solubilization, refolding and purification of recombinant human IL-2. The strategy employed has been to purify IL-2 partially in denatured form and then, following preliminary refolding experiments aimed at identification of the correctly folded species, to improve the recovery of this species by systematic examination of the folding conditions and to develop a purification scheme based on these data.
MATERIALS AND METHODS Molecular genetics
A synthetic gene coding for the mature 133-residue protein was constructed on the basis of the cDNA sequence determined by Taniguchi et al. (1983) , cloned and expressed in E. coli RB791. The IL-2 expression vector pTIL2E/2TT is a derivative of pAT153 (Twigg & Sherrat, 1980) containing the hybrid tac promoter from pDR540 (Russell & Bennett, 1982) inserted between the restriction-endonuclease-HindIII and BamHI sites, a synthetic IL-2 gene inserted between the BamHI and Sall sites and a synthetic Trp A transcription terminator (Christie et al., 1981) between the Sall and AvaI sites. The synthetic IL-2 gene was composed of single-stranded oligonucleotides which were synthesized by the solidphase phosphotriester methodology using a Biosearch Synthesis Automation Machine (Applied Biosystems) and ligated as described by Sagaramella & Khorana (1972) . Codon usage was chosen for optimal expression in E. coli. The gene sequence was checked and was found to be correct. Growth and disruption of cells A 50 ml sample of an E. coli RB791 culture containing the IL-2 plasmid was grown overnight to stationary phase and this culture was used to inoculate 5 litres of medium in shake flasks. After 1 h at 37°C cells were induced to produce IL-2 with isopropyl /8-thiogalactoside, grown for 3 h and chloroform-killed. Cells (15-20 g wet wt.) were harvested in a Beckman J2-21 centrifuge at 2800 g for 5 min and disrupted by M P.. Weir aTd J Spars sonication in 50 ml of 10 mM-phosphate buffer, pH 7.4, containing 0. 15 M-NaCI/10 mM-EDTA/ 10mM DTT, the IL-2 inclusion bodies penleted by centrifugation at 10000 g for 10 min and the pellet resuspended in, an equal: volume of the above buffer for use in subsequent experiments. Solubiization of inclusion bodies, Solubilization was monitored by SDS/PAGE'. Samples (100, #1) of pellet suspension were centrifuged at 10000 g for 5 min and pellets were resuspended in 100 ItI of solvent and left for 10 min at 20 'C. After recentrifugation supernatants were dialysed against 50 mmTris/HCl, pH 6.8; 2-ME (5% v/v) and SDS (1%) were added and samples boiled for 5 min. Pellets were washed with 190 mM-Tris/HCl, pH 6.8, boiled in 100 ,ul of sample buffer to extract the remaining proteins, and re-centrifuged to remove particulate matter. Samples (50 ,ul) of supernatants and pellet extracts were loaded on to gels and, after electrophoresis, proteins were revealed by staining with Coomassie Blue. G.pxc.
Analytical g.p.c. was performed i'n 6 M-GdmCl/50 mMTris/HCl (pH 8.5)/10 mM-DTT (running buffer) with a 1 cm x 30 cm Pharmacia Superose 12 f.p.l.c. column and a Pharmacia f.p.l.c. apparatus; the flow rate was 0.5 ml/min. Samples (200 ,ll) of pellet suspension were centrifuged at 10000 g for 5 min and the pellet dissolved in 8 M-GdmCl/10 mM-DTT, pH 8.5,, for 1 h at 37 'C to ensure complete reduction and solubilization before chromatography. Preparative g.p.c. was performed on a 5 cm x 90 cm Sepharose CL-6B column equilibrated in running buffer and run at a flow rate of 70 ml/h; 40 ml of pellet suspension was centrifuged im a. Beckman J2-21 centrifuge (JA-17 rotor) at 7000 g for O min and the pellet resuspended in 15 ml of 8 M-GdmCl/1O mM-DTT to give a finaf volume of 20 ml. IL-2-containing fractions were identified by silver staining after SDS/PAGE, pooled and stored at -70. 'C. Pools were respectively termed ' g.p.c.-f.p.l.c.' and. 'g.p.c.-6B'. To, study oxidation in the absence of DTT, g.p.c.-B pools were desalted in 6 M-GdmCl/0.1 % TFA, pH 2.2, using a Pharmacia PD-10 gel-filtration column;. this material ('g..pc.-DS') was used within a few hours, since autaxidation is still appreciable,, even at this pH (Saxena & Weiaufer, 1970 were obtained from Anachem. Fractions were stored at -70 'C. The amount of IL-2 proteitm was determined from peak areas using an A28e0 value of 9.58 x 103 M-1 -cm-' (Kato et al., 1985) } SDS/PAGE and gel seanning SDS/PAGE was performed with 15%-(w/v)-polyacrylamide gels as described by Laemmli (1970) . H.p.l.c. column fractions in acetonitrile were 3-fold diluted in sample buffer [190 mM-Tris/HCI (pH 6.8)/3% (w/v) SDS/30% (v/v) glycerol/0.75% (v/v) Bromophenol Blue/5% (v/v) 2-ME]. Gels were silver-stained (Wray et al., 1981) or Coomassie Blue R-250-stained. Protein standards (Pharmacia) were phosphorylase b (molecular mass 94 kDa), BSA (67 kDa), ovalbumin (43 kDa), carbonic anhydrase (30 kDa), soybean trypsin inhibitor (20.1 kDa) and a-lactalbumin (14.4 kDa). For quantification of IL-2 in g.p.c. pools, silver-stained gels were scanned densitometrically with a Joyce-Loebl Chromoscan-3 densitometer. Loads (50-500 ng) of h.p.l.c.-purified IL-2, of known concentration (determined by RP-h.p.l.c. peak area), were used for calibration, and samples were loaded at such dilution that their IL-2 content fell within this range. Total protein was measured by the Bradford method (Pierce Protein Assay Reagent). Bioassay Amounts (in units) of IL-2 were estimated with an IL-2-dependent cell-proliferation assay, essentially as described by Gillis et al. (1978) , the murine T-cytotoxic cell line CTL-L being used. Table 1 for the various solvents tried. DTT at 10 mm was sometimes included, but made no observable difference to solubilization. Fig. 1 shows an SDS/PAGE gel monitoring extraction by acetic acid, formic acid and GdmCl; acetic acid at concentrations greater than 50% (v/v) did not effect greater solubilization, and below this concentration there was a steady decrease in percentage solubilization until the latter was negligible at 10% (v/v) acetic acid. A similar gradation was observed with formic acid, 2-6 M-GdmHCl and 4-8 M-urea; the high density of the latter two solvents may mean that some aggregated or membrane-associated protein did not spin down, although g.p.c. showed that 6 M-GdmCl was an effective solvent (see below). Since increasing solvent volume and time of extraction had little effect, and also re-extraction of pellet from 50% acetic acid solubilization did not further dissolve IL-2, it appeared the IL-2 is heterogeneous with respect to solubilization.
GdmCI was chosen as solvent because of the relative ease of renaturation by dilution and the low risk of covalent modification of the protein when compared with the situation with other solvents. This solvent was also employed by Kato et al. (1985) . G.p.c.
G.p.c. in 6 M-GdmCl/l0 mM-DTT achieved a 2.5-3-fold purification of IL-2 before the renaturation step (Fig. 2) . IL-2 was detected by SDS/PAGE and by bioassay of fractions and was eluted at a position corresponding to an Mr of about 15000, indicating that it was unfolded and monomeric under these conditions. The purification is evident in densitometer scans (Fig. 3 Vol. 245 (Fig. 2b) . The IL-2 concentration in g.p.c. pools (Table 2) was estimated from the peak area in densitometer scans by reference to a calibration curve of pure IL-2 standards (of known concentration as determined by RP-h.p.l.c. peak area) loaded on to the same gel. The relationship of peak area to IL-2 load was linear between 50 and 500 ng, and sample loads were adjusted to fall within this range. 0-82% B, 10 min; 82%B, 10 min; 82-100%B, 24 min; the flow rate was 0.5 ml/min. Two IL-2 peaks, X and Y, were identified by SDS/PAGE; they were eluted at 56.5% and 59.5% acetonitrile respectively. Peak X was oxidized IL-2 and Y was reduced IL-2.
was seen as both protein and IL-2 concentrations were decreased concomitantly (Table 3) ; recovery was increased 1.7-fold with a 10-fold decrease in concentration. Presumably aggregation or misdirected folding was responsible. Protein concentration alone had no significant effect on recovery, whereas the concentration of IL-2 did ( Table 3 ), indicating that a specific process was responsible. However, recoveries after renaturation of unpurified GdmCl extracts were only about 5%, possibly owing to interference from high-Mr membrane fragments or protein aggregates. The fate ofaggregated or misfolded IL-2 on RP-h.p.l.c. is unclear; a weak IL-2 band comprising less than 5% of the total IL-2 was seen, on SDS/PAGE, at around 45% (v/v) acetonitrile (19 min) in the gradient (Fig. 4) , but no other species were detected. Aggregates are most likely to be found in the unretained fractions, although no bioactivity was detected in these fractions. Subdenaturing concentrations of chaotrope have been seen to inhibit aggregation (Orsini & Goldberg, 1978) , but 2 M-GdmCl had no effect on peak-X recovery, nor did 20% (v/v) acetonitrile or 25% (v/v) ethylene glycol. 2, 500 rig of IL-2 peak X (see Fig. 4 ) from C18 h.p.l.c. of refolded g.p.c.-f.p.l.c. protein (samples for tracks 1 and 2 were reduced with 2-ME); track 3, sample as track 2, but unreduced, indicating little dimer in this preparation (although the latter is sometimes observed). The apparent Mr of IL-2 (calculated from the standards) was 15030. (Table 4) . Clearly, Cu2+ speeds the rate of autoxidation, as has been observed for ribonuclease (Ahmed et al., 1975) and lysozyme (Yutani et al., 1968) . Yields of IL-2 were similar to those obtained in the presence of DTT; however, if g.p.c.-DS samples were left at 4°C in air for 24 h, substantial decreases in peak-X yield were observed that were reversed by reduction and reoxidation, indicating the formation of wrong disulphide isomer(s) in the unfolded polypeptide. GSSG/GSH mixtures also led to efficient oxidation (Table 4 ). The improved rate in the presence of GSH compared with GSSG alone indicates that thioldisulphide reactions were rate-limiting in glutathione oxidation of IL-2, with mixed disulphide accumulating in the absence of free thiol (Creighton, 1978) . Although rates were good with GSSG/GSH, there was the possibility that the third thiol of IL-2 had become derivatized, hence Cu2+/02 was considered the better oxidant.
Renaturation and purification protocol
On the basis of observations that IL-2 must be kept reduced during purification in GdmCl but that its oxidation/renaturation is inhibited by high levels of DTT, f.p.l.c. gel permeation was performed in 6 MGdmCl/ 1 mM-DTT/20 mM-acetate buffer, pH 5; IL-2 remained reduced under these conditions for several days. Renaturation and autoxidation was effected at pH 8.5 in the presence of Cu2+; oxidation was attempted at lower pH values in the hope of increasing the yield, but was found to be extremely slow below pH 6. With IL-2 concentrations in the region of 1-2,g/ml, highly purified IL-2 could be prepared conveniently at the 50 ,ug level of analytical RP-h.p.l.c. (Table 5 ). Since IL-2 will remain reduced on the time scale of preparative g.p.c. and, furthermore, renaturation is possible in bulk solutions, then this methodology is amenable to scaling up to at least the milligram level.
DISCUSSION
Many heterologous proteins are expressed in E. coli as aggregates (Marston et al., 1984) ; given the harsh conditions required to solubilize totally such IL-2 aggregates, it seems likely that much of this protein is improperly folded. The causes of inclusion-body formation are unclear; it may be that the nascent polypeptide aggregates in a manner analogous to that seen here in vitro; precipitation of folding intermediates has been demonstrated in vivo for P22 tailspike endorhamnosidase (King, 1986) . IL-2 is a secreted protein and, in the eukaryotic cell, has a 19-residue signal sequence (Taniguchi et al., 1983) that is lacking in our construct and may prevent aggregation by binding to the signal-recognition particle/endoplasmic reticulum (Walter & Blobel, 1982) and immobilizing the chain during folding. The lack of glycosylation of recombinant IL-2 (Liang et al., 1985) is unlikely to play a part in aggregation, since 20% of native human IL-2 from cell culture is also unglycosylated (Robb et al., 1984) .
The assignment of peak X as conformationally correct IL-2 was based on specific activity and on evidence of oxidation. The Mr determination by SDS/PAGE showed that the polypeptide was largely intact; N-or C-terminal proteolysis remains a possibility on this evidence, although none has been reported for recombinant IL-2 from E. coli, except for variable aminopeptidase removal of the initiator methionine (Kato et al., 1985; Liang et al., 1985; Yamada et al., 1986) .
Assignment of peak X as correctly oxidized protein, with the Cys-58-Cys-105 disulphide bridge formed, was confirmed by its retention time on RP-h.p.l.c.; the mispaired isomers Cys-58-Cys-125 and Cys-105-Cys-125 are eluted much earlier in the gradient (Browning et al., 1986) and may be responsible for the minor IL-2 peak at 45% acetonitrile. Recovery of Cys-58-Cys-105 IL-2 was much diminished if the protein was allowed to oxidize when denatured, since the Cys-105-Cys-125 bridge will predominate under these conditions (Browning et al., 1986) and, in the absence of added thiol, reshuffling to the correct isomer did not occur at a significant rate on refolding.
In summary, the recovery of IL-2 renatured from seni-purified extracts of E. coil has been improved by examination of the folding and oxidation conditions; such a strategy should also be useful for the production of other recombinant proteins that need to be denaturantextracted and do not refold easily in high yield.
